Altium Wealth Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $169K | Hold |
16,000
| – | – | 0.01% | 351 |
|
|
2022
Q1 | $260K | Hold |
16,000
| – | – | 0.02% | 328 |
|
|
2021
Q4 | $222K | Hold |
16,000
| – | – | 0.01% | 351 |
|
|
2021
Q3 | $230K | Buy |
16,000
+1,000
| +7% | +$14.4K | 0.02% | 339 |
|
|
2021
Q2 | $237K | Hold |
15,000
| – | – | 0.02% | 342 |
|
|
2021
Q1 | $153K | Sell |
15,000
-350
| -2% | -$3.57K | 0.01% | 366 |
|
|
2020
Q4 | $114K | Buy |
15,350
+5,000
| +48% | +$37.1K | 0.01% | 341 |
|
|
2020
Q3 | $36K | Buy |
+10,350
| New | +$36K | ﹤0.01% | 336 |
|